Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | Patent Number RE049353

US RE049353 E1
Application Number16998683
Publication Number-
Pendency2 years, 4 months, 16 days
Filled DateAug 20, 2020
Priority DateSep 26, 2012
Publication Date-
Expiration DateSep 25, 2032
Inventor/ApplicantsIsan Chen
ExaminesJOHNSON, JERRY D
Art Unit3991
Technology Center3900
Assignments
Johnson & Johnson
Current
Aragon Pharmaceuticals Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.